US Broker Ratings

Azenta, Inc. (AZTA) Stock Analysis: Exploring the 89% Potential Upside

Investors seeking opportunities in the healthcare sector may want to turn their attention to Azenta, Inc. (NASDAQ: AZTA), a company that is making strides in the life sciences industry with..

Tandem Diabetes Care, Inc. (TNDM): Investor Outlook on a Medical Device Innovator with 21% Potential Upside

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) is a key player in the healthcare sector, specifically within the medical devices industry, focusing on advanced technology solutions for diabetes management. Headquartered in..

Vera Therapeutics, Inc. (VERA) Stock Analysis: Promising 93.96% Upside Sparks Investor Interest

For investors seeking opportunities in the healthcare sector, Vera Therapeutics, Inc. (NASDAQ: VERA) presents a compelling prospect. Specializing in the biotechnology industry, this California-based company is at the forefront of..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: Eyeing a 47% Potential Upside with Biotech Innovations

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a prominent player in the biotechnology sector, is garnering significant attention from investors due to its innovative approach in developing therapeutic solutions for eye care...

MannKind Corporation (MNKD) Stock Analysis: Exploring a 207% Upside Potential Amidst Strong Revenue Growth

MannKind Corporation (NASDAQ: MNKD) stands at an intriguing crossroads for investors seeking exposure to the biotechnology sector. With its focus on innovative solutions for chronic diseases like diabetes and pulmonary..

Structure Therapeutics Inc. (GPCR) Stock Analysis: A Biotech Play with 122% Potential Upside

For investors seeking high-reward opportunities in the biotechnology sector, Structure Therapeutics Inc. (NASDAQ: GPCR) presents a compelling case. With an impressive potential upside of 122.18%, according to analyst ratings, this..

Perrigo Company plc (PRGO) Stock Analysis: Exploring a Potential Upside of 77.64% Amidst Volatility

Perrigo Company plc (NYSE: PRGO), a prominent player in the healthcare sector, operates within the niche of specialty and generic drug manufacturing. Headquartered in Dublin, Ireland, Perrigo offers a plethora..

Liquidia Corporation (LQDA) Investor Outlook: Analysts See 40% Upside Potential in Biopharma Innovator

Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company at the forefront of rare cardiopulmonary disease treatment, has captured investors’ attention with its potential for significant stock price appreciation. With a market..

U.S. Physical Therapy, Inc. (USPH) Investor Outlook: Exploring a 38.30% Potential Upside

U.S. Physical Therapy, Inc. (NYSE: USPH) stands as a noteworthy player in the healthcare sector, specifically in the medical care facilities industry. Headquartered in Houston, Texas, the company has carved..

Mesoblast Limited (MESO) Stock Analysis: A Biotech with 149% Upside Potential Amidst Rapid Revenue Growth

Investors with a keen eye on the biotechnology sector might find Mesoblast Limited (NASDAQ: MESO) an intriguing opportunity. Headquartered in Melbourne, Australia, Mesoblast is a prominent player in the healthcare..

Adaptive Biotechnologies Corp (ADPT) Stock Analysis: A 52.69% Potential Upside Beckons Investors

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) is a name that resonates well within the healthcare sector, particularly among those tracking the dynamic biotechnology industry. With a market capitalization of $2.1 billion,..

Artivion, Inc. (AORT) Stock Analysis: Exploring a Potential 44% Upside in the Medical Devices Sector

Artivion, Inc. (NASDAQ: AORT) stands as a notable player within the healthcare sector, specifically in the medical devices industry. Headquartered in Kennesaw, Georgia, Artivion specializes in manufacturing and distributing a..

NovoCure Limited (NVCR) Stock Analysis: Exploring a 119% Potential Upside in the Medical Device Sector

NovoCure Limited (NASDAQ: NVCR), a prominent player in the medical device sector, is making waves with its innovative tumor treating fields (TTFields) technology. Headquartered in Baar, Switzerland, NovoCure specializes in..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Navigating a 50.81% Potential Upside

Investors with a keen eye for opportunity should pay close attention to Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a dynamic player in the healthcare sector, known for its robust portfolio of..

Acadia Healthcare Company, Inc. (ACHC) Stock Analysis: Evaluating the Challenges and Opportunities

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) is a prominent player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $2.14 billion, the company..

Certara, Inc. (CERT) Stock Analysis: Exploring a 44.69% Potential Upside Amid Healthcare Innovation

Certara, Inc. (NASDAQ: CERT), a prominent player in the healthcare sector, is drawing investor attention with a promising 44.69% potential upside, as signaled by analyst ratings. With its niche focus..

Select Medical Holdings Corp (SEM) Stock Analysis: Evaluating Growth Potential with a Strategic Focus in Healthcare

Select Medical Holdings Corporation (NYSE: SEM) operates within the healthcare sector, specializing in medical care facilities across the United States. With a market capitalization of $2.02 billion, Select Medical has..

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: Exploring a Potential 73% Upside in the Biotech Sector

Celldex Therapeutics, Inc. (NASDAQ: CLDX), a key player in the biotechnology sector, offers an intriguing investment narrative with its advanced pipeline of therapeutic antibodies aimed at addressing severe inflammatory, allergic,..

LivaNova PLC (LIVN) Stock Analysis: Evaluating a 26% Upside Potential in the Medical Device Sector

LivaNova PLC (NASDAQ: LIVN), a prominent player in the medical device industry, has been capturing investor attention with its robust growth prospects and strategic positioning in the healthcare sector. Headquartered..

PROCEPT BioRobotics Corporation (PRCT) Stock Analysis: Unveiling a 24% Potential Upside

PROCEPT BioRobotics Corporation (NASDAQ: PRCT), a pioneering name in the medical devices sector, is capturing investor attention with its innovative approach to urologic surgery. With a market capitalization of $1.47..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds